RT Journal Article SR Electronic T1 Mechanisms of Resistance to PARP Inhibitors—Three and Counting JF Cancer Discovery JO CANCER DISCOVERY FD American Association for Cancer Research SP 20 OP 23 DO 10.1158/2159-8290.CD-12-0514 VO 3 IS 1 A1 Fojo, Tito A1 Bates, Susan YR 2013 UL http://cancerdiscovery.aacrjournals.org/content/3/1/20.abstract AB Summary: Given the malleable nature of cancer cells, we should expect, and do see, the development of resistance to any new chemotherapeutic agent. Models that help us understand how this happens are a first step to better and more effective chemotherapeutics. Cancer Discov; 3(1); 20–3. ©2012 AACR. See related article by Jaspers et al., p. 68